^ No, the biggest hurdle is consistency of product.
Even in places like Cali, where you can stroll down to your local dispensary, chat to a bud tender, and walk out with x grams of Grandaddy Purple (pick a strain) that worked well last month, but for some reason fails to deliver this time around. There will always be variables in the grow cycle that alters the canabinoid and terpene profile.
For this his reason many people who've been down the cannabis track to treat specific illness are now moving back to pharma.
The only potential I now I realistically see in quantity take up of cannabis is to market it as a superfood, or something similar to BS prods like Blackmores i.e. sell lazy consumerists FOMO.
CGB Price at posting:
3.7¢ Sentiment: None Disclosure: Held
